TIL stock falls after reprioritization of pipeline (NASDAQ:TIL) Markets December 8, 2022 [ad_1] No-Mad Instil Bio (NASDAQ:TIL) introduced an roughly 60% discount in its U.S. headcount on Thursday as cancer-focused biotech undertook…
